Stem cells in the heart: What's the buzz all about? Part 2: Arrhythmic risks and clinical studies

Heart Rhythm

Volumn 5, Issue 6, 2008, Pages 880-887

  Smith, Rachel Ruckdeschel ^a   Barile, Lucio ^b   Messina, Elisa ^b   Marbán, Eduardo ^c  

^a Capricor Inc   (United States)

^b Pasteur Institute   (Italy)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Arrhythmia; Cardiac stem cells; Myocardial infarction; Myocardial regeneration

Indexed keywords

CD133 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CONNEXIN 43; ENDOGLIN; PLACEBO; STEM CELL ANTIGEN 1; STEM CELL FACTOR RECEPTOR; THY 1 ANTIGEN; VASCULOTROPIN RECEPTOR 2; VERY LATE ACTIVATION ANTIGEN 4;

ACUTE HEART INFARCTION; ANGIOGENESIS; ARRHYTHMOGENESIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CARDIOVASCULAR RISK; CELL DIFFERENTIATION; CELL FUSION; CELL POPULATION; CELL PROLIFERATION; CELL REGENERATION; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; ENDOTHELIUM CELL; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE CELL; HEART VENTRICLE TACHYCARDIA; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INCIDENCE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOBLAST; NONHUMAN; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK BENEFIT ANALYSIS; SAFETY; STEM CELL TRANSPLANTATION; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ARRHYTHMIAS, CARDIAC; CELL FUSION; CLINICAL TRIALS AS TOPIC; ENDOTHELIUM, VASCULAR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MUSCLE, SKELETAL; MYOBLASTS; MYOCARDIAL INFARCTION; MYOCARDIUM; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 46349110514     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2008.02.011     Document Type: Article

References (96)

1. Bolli R., Jneid H., and Dawn B. Bone marrow cell-mediated cardiac regeneration a veritable revolution. J Am Coll Cardiol 46 (2005) 1659-1661
2. Nussbaum J., Minami E., Laflamme M.A., et al. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. Faseb J 21 (2007) 1345-1357
3. Menasche P., Hagege A.A., Vilquin J.T., et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41 (2003) 1078-1083
4. Siminiak T., Kalawski R., Fiszer D., et al. Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up. Am Heart J 148 (2004) 531-537
5. Smits P.C., van Geuns R.J., Poldermans D., et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J Am Coll Cardiol 42 (2003) 2063-2069
6. Takahashi K., and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006) 663-676
7. Takahashi K., Tanabe K., Ohnuki M., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 (2007) 861-872
8. Yu J., Vodyanik M.A., Smuga-Otto K., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318 (2007) 1917-1920
9. Nakagawa M., Koyanagi M., Tanabe K., et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26 (2008) 101-106
10. Byrne J.A., Pedersen D.A., Clepper L.L., et al. Producing primate embryonic stem cells by somatic cell nuclear transfer. Nature 450 (2007) 497-502
11. Laflamme M.A., Chen K.Y., Naumova A.V., et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 25 (2007) 1015-1024
12. Dai W., Field L.J., Rubart M., et al. Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts. J Mol Cell Cardiol 43 (2007) 504-516
13. Caspi O., Huber I., Kehat I., et al. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am Coll Cardiol 50 (2007) 1884-1893
14. Okada S., Nakauchi H., Nagayoshi K., et al. In vivo and in vitro stem cell function of c-kit- and Sca-1-positive murine hematopoietic cells. Blood 80 (1992) 3044-3050
15. Lagostena L., Avitabile D., De Falco E., et al. Electrophysiological properties of mouse bone marrow c-kit+ cells co-cultured onto neonatal cardiac myocytes. Cardiovasc Res 66 (2005) 482-492
16. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infarcted myocardium. Nature 410 (2001) 701-705
17. Kajstura J., Rota M., Whang B., et al. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res 96 (2005) 127-137
18. Rota M., Kajstura J., Hosoda T., et al. Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc Natl Acad Sci U S A 104 (2007) 17783-17788
19. Orlic D., Kajstura J., Chimenti S., et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 98 (2001) 10344-10349
20. Dawn B., Guo Y., Rezazadeh A., et al. Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function. Circ Res 98 (2006) 1098-1105
21. Balsam L.B., Wagers A.J., Christensen J.L., et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428 (2004) 668-673
22. Murry C.E., Soonpaa M.H., Reinecke H., et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428 (2004) 664-668
23. Nygren J.M., Jovinge S., Breitbach M., et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 10 (2004) 494-501
24. Civin C.I., and Gore S.D. Antigenic analysis of hematopoiesis: a review. J Hematother 2 (1993) 137-144
25. Yeh E.T., Zhang S., Wu H.D., et al. Transdifferentiation of human peripheral blood CD34+-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation 108 (2003) 2070-2073
26. Zhang S., Wang D., Estrov Z., et al. Both cell fusion and transdifferentiation account for the transformation of human peripheral blood CD34-positive cells into cardiomyocytes in vivo. Circulation 110 (2004) 3803-3807
27. Hruban R.H., Long P.P., Perlman E.J., et al. Fluorescence in situ hybridization for the Y-chromosome can be used to detect cells of recipient origin in allografted hearts following cardiac transplantation. Am J Pathol 142 (1993) 975-980
28. Quaini F., Urbanek K., Beltrami A.P., et al. Chimerism of the transplanted heart. N Engl J Med 346 (2002) 5-15
29. Laflamme M.A., Myerson D., Saffitz J.E., et al. Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ Res 90 (2002) 634-640
30. Glaser R., Lu M.M., Narula N., et al. Smooth muscle cells, but not myocytes, of host origin in transplanted human hearts. Circulation 106 (2002) 17-19
31. Minami E., Laflamme M.A., Saffitz J.E., et al. Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart. Circulation 112 (2005) 2951-2958
32. Kamihata H., Matsubara H., Nishiue T., et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104 (2001) 1046-1052
33. Tomita S., Mickle D.A., Weisel R.D., et al. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg 123 (2002) 1132-1140
34. Waksman R., Fournadjiev J., Baffour R., et al. Transepicardial autologous bone marrow-derived mononuclear cell therapy in a porcine model of chronically infarcted myocardium. Cardiovasc Radiat Med 5 (2004) 125-131
35. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
36. Urbich C., and Dimmeler S. Endothelial progenitor cells functional characterization. Trends Cardiovasc Med 14 (2004) 318-322
37. Badorff C., Brandes R.P., Popp R., et al. Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 107 (2003) 1024-1032
38. Kawamoto A., Gwon H.C., Iwaguro H., et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103 (2001) 634-637
39. Kocher A.A., Schuster M.D., Szabolcs M.J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7 (2001) 430-436
40. Iwasaki H., Kawamoto A., Ishikawa M., et al. Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction. Circulation 113 (2006) 1311-1325
41. Kawamoto A., Tkebuchava T., Yamaguchi J., et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 107 (2003) 461-468
42. Kawamoto A., Iwasaki H., Kusano K., et al. CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells. Circulation 114 (2006) 2163-2169
43. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
44. Kadivar M., Khatami S., Mortazavi Y., et al. In vitro cardiomyogenic potential of human umbilical vein-derived mesenchymal stem cells. Biochem Biophys Res Commun 340 (2006) 639-647
45. Xu W., Zhang X., Qian H., et al. Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Exp Biol Med (Maywood) 229 (2004) 623-631
46. Shim W.S., Jiang S., Wong P., et al. Ex vivo differentiation of human adult bone marrow stem cells into cardiomyocyte-like cells. Biochem Biophys Res Commun 324 (2004) 481-488
47. Oswald J., Boxberger S., Jorgensen B., et al. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 22 (2004) 377-384
48. Nagaya N., Fujii T., Iwase T., et al. Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol 287 (2004) H2670-H2676
49. Dai W., Hale S.L., Martin B.J., et al. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation 112 (2005) 214-223
50. Amado L.C., Saliaris A.P., Schuleri K.H., et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A 102 (2005) 11474-11479
51. Makkar R.R., Price M.J., Lill M., et al. Intramyocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model of myocardial infarction. J Cardiovasc Pharmacol Ther 10 (2005) 225-233
52. Nagaya N., Kangawa K., Itoh T., et al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 112 (2005) 1128-1135
53. Mazhari R., and Hare J.M. Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche. Nat Clin Pract Cardiovasc Med 4 Suppl 1 (2007) S21-S26
54. Breitbach M., Bostani T., Roell W., et al. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 110 (2007) 1362-1369
55. Aggarwal S., and Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105 (2005) 1815-1822
56. Jain M., DerSimonian H., Brenner D.A., et al. Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation 103 (2001) 1920-1927
57. He K.L., Yi G.H., Sherman W., et al. Autologous skeletal myoblast transplantation improved hemodynamics and left ventricular function in chronic heart failure dogs. J Heart Lung Transplant 24 (2005) 1940-1949
58. Leobon B., Garcin I., Menasche P., et al. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci U S A 100 (2003) 7808-7811
59. Abraham M.R., Henrikson C.A., Tung L., et al. Antiarrhythmic engineering of skeletal myoblasts for cardiac transplantation. Circ Res 97 (2005) 159-167
60. Roell W., Lewalter T., Sasse P., et al. Engraftment of connexin-43-expressing cells prevents post-infarct arrhythmia. Nature 450 (2007) 819-824
61. Heubach J.F., Graf E.M., Leutheuser J., et al. Electrophysiological properties of human mesenchymal stem cells. J Physiol 554 (2004) 659-672
62. Li G.R., Sun H., Deng X., et al. Characterization of ionic currents in human mesenchymal stem cells from bone marrow. Stem Cells 23 (2005) 371-382
63. Chang M.G., Tung L., Sekar R.B., et al. Proarrhythmic potential of mesenchymal stem cell transplantation revealed in an in vitro coculture model. Circulation 113 (2006) 1832-1841
64. Price M.J., Chou C.C., Frantzen M., et al. Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties. Int J Cardiol 111 (2006) 231-239
65. Pijnappels D.A., Schalij M.J., van Tuyn J., et al. Progressive increase in conduction velocity across human mesenchymal stem cells is mediated by enhanced electrical coupling. Cardiovasc Res 72 (2006) 282-291
66. Chen X., Wilson R.M., Kubo H., et al. Adolescent feline heart contains a population of small, proliferative ventricular myocytes with immature physiological properties. Circ Res 100 (2007) 536-544
67. Beltrami A.P., Barlucchi L., Torella D., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114 (2003) 763-776
68. Messina E., De Angelis L., Frati G., et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 95 (2004) 911-921
69. Smith R.R., Barile L., Cho H.C., et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 115 (2007) 896-908
70. Dawn B., Stein A.B., Urbanek K., et al. Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci U S A 102 (2005) 3766-3771
71. Bearzi C., Rota M., Hosoda T., et al. Human cardiac stem cells. Proc Natl Acad Sci U S A 104 (2007) 14068-14073
72. Osiris Therapeutics Announces Positive Results in Groundbreaking Stem Cell Trial to Treat Heart Disease. http://investor.osiris.com/releasedetail.cfm?ReleaseID=235227 Access 3/25/07
73. Katritsis D.G., Sotiropoulou P., Giazitzoglou E., et al. Electrophysiological effects of intracoronary transplantation of autologous mesenchymal and endothelial progenitor cells. Europace 9 (2007) 167-171
74. Wang X., Willenbring H., Akkari Y., et al. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 422 (2003) 897-901
75. Weimann J.M., Johansson C.B., Trejo A., et al. Stable reprogrammed heterokaryons form spontaneously in Purkinje neurons after bone marrow transplant. Nat Cell Biol 5 (2003) 959-966
76. Cowan C.A., Atienza J., Melton D.A., et al. Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 309 (2005) 1369-1373
77. Matsuura K., Wada H., Nagai T., et al. Cardiomyocytes fuse with surrounding noncardiomyocytes and reenter the cell cycle. J Cell Biol 167 (2004) 351-363
78. Zhang S., Shpall E., Willerson J.T., et al. Fusion of human hematopoietic progenitor cells and murine cardiomyocytes is mediated by alpha 4 beta 1 integrin/vascular cell adhesion molecule-1 interaction. Circ Res 100 (2007) 693-702
79. Chen E.H., and Olson E.N. Unveiling the mechanisms of cell-cell fusion. Science 308 (2005) 369-373
80. Hagege A.A., Marolleau J.P., Vilquin J.T., et al. Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients. Circulation 114 Suppl (2006) I108-I113
81. Menasche P. First randomized placebo-controlled Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial. Circulation 114 (2006) 2426
82. MG Biotherapeutics, LLC (2007). http://www.mgbiotherapeutics.com/research/MAGIC/mgb_en_p_rd_magicresults.asp Clinical MAGIC Results. Accessed May 7, 2008
83. Schachinger V., Assmus B., Britten M.B., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 44 (2004) 1690-1699
84. Schachinger V., Erbs S., Elsasser A., et al. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J 27 (2006) 2775-2783
85. Lunde K., Solheim S., Aakhus S., et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 355 (2006) 1199-1209
86. Seeger F.H., Tonn T., Krzossok N., et al. Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur Heart J 28 (2007) 766-772
87. Wollert K.C., Meyer G.P., Lotz J., et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364 (2004) 141-148
88. Meyer G.P., Wollert K.C., Lotz J., et al. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113 (2006) 1287-1294
89. Perin E.C., Dohmann H.F., Borojevic R., et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107 (2003) 2294-2302
90. Perin E.C., Dohmann H.F., Borojevic R., et al. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation 110 Suppl 1 (2004) II213-II218
91. Dohmann H.F., Perin E.C., Takiya C.M., et al. Transendocardial autologous bone marrow mononuclear cell injection in ischemic heart failure: postmortem anatomicopathologic and immunohistochemical findings. Circulation 112 (2005) 521-526
92. Strauer B.E., Brehm M., Zeus T., et al. Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study. J Am Coll Cardiol 46 (2005) 1651-1658
93. Lipinski M.J., Biondi-Zoccai G.G., Abbate A., et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol 50 (2007) 1761-1767
94. Torella D., Ellison G.M., Karakikes I., et al. Growth-factor-mediated cardiac stem cell activation in myocardial regeneration. Nat Clin Pract 4 Suppl 1 (2007) S46-S51
95. Penn M.S. Cell-based gene therapy for the prevention and treatment of cardiac dysfunction. Nat Clin Pract 4 Suppl 1 (2007) S83-S88
96. Ellison G.M., Torella D., Karakikes I., et al. Myocyte death and renewal: modern concepts of cardiac cellular homeostasis. Nat Clin Pract 4 Suppl 1 (2007) S52-S59